Yahoo! Finance: Top Stories

ImmunityBio (IBRX) Attains FDA’s Expanded Access Authorization for its Cancer BioShield Platform Anchored by ANKTIVA

Jun 26, 2025 - 08:18
 0
ImmunityBio (IBRX) Attains FDA’s Expanded Access Authorization for its Cancer BioShield Platform Anchored by ANKTIVA
Read More

Tags:

Previous Article

How ETFs Give Investors Tools to Manage Diverse Market Conditions

Next Article

Jefferies Maintains a Buy on Taysha Gene Therapies (TSHA) With an $8 PT

Related Posts

Oil Falls With Investor Optimism Building About Mideast Conflict

Oil Falls With Investor Optimism Building About Mideast...

Jun 18, 2025  0

HP (HPQ) Joins Google to Power ‘Beam,’ an AI-First 3D Video Chat Experience

HP (HPQ) Joins Google to Power ‘Beam,’ an AI-First 3D V...

May 22, 2025  0

Stock market today: Dow, S&P 500, Nasdaq climb as Trump eyes naming a replacement for Fed's Powell

Stock market today: Dow, S&P 500, Nasdaq climb as Trump...

Jun 26, 2025  0